Company / Cash & Equivalents
Cadre Holdings, Inc. Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$122.9M
FY2025
5-year range
$33.9M / $124.9M
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#103 of 148
Health Care
What the data says
At $123M, Cadre Holdings, Inc.'s cash & equivalents ranks #103 of 148 in the Health Care sector. Improved from $88M to $123M over the past 2 years.
Based on SEC 10-K filings.
$123M in FY2025 with a 5-year CAGR of +112.0%.
Improved from $88M to $123M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +39.5%
- 5-Year CAGR
- +112.0%
- 10-Year CAGR
- -
Sector benchmark
#103 of 148 in Health CareTop 70% of 148This company $122.9M Sector average $1.2B
▼
-89.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +112.0%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 1.6% year-over-year.
- Ranks #103 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2024.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $122.9M | -1.6% |
| FY2024 | $124.9M | +42.5% |
| FY2023 | $87.7M | +93.6% |
| FY2022 | $45.3M | +33.8% |
| FY2021 | $33.9M | +1078.5% |
| FY2020 | $2.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026